JEK Trust seeks to sell 180,000 ALHC shares (NASDAQ: ALHC)
Rhea-AI Filing Summary
JEK TRUST reported a proposed sale of 180,000 shares of Common Stock in a Form 144 filing. The filing lists an aggregate amount of $3,279,600.00 and references NASDAQ trading with a context figure of 204,296,493 shares and the date 03/10/2026.
The excerpt also shows prior 10b5-1 activity by the same trust: sales of 180,000 shares on 02/10/2026 and 01/12/2026 (amounts listed), and an earlier sale of 605,648 shares on 12/29/2025. The filing lists Morgan Stanley Smith Barney LLC in the securities section.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies regulator of an intended resale under Rule 144 mechanics.
The filing lists a proposed resale of 180,000 shares with an aggregate amount of
Cash‑flow treatment and specific distribution methods are not detailed in the excerpt; subsequent filings or broker disclosures would show execution details and settlement counterparties.
Transaction size is traceable but appears routine for an institutional trust.
The filing shows a single proposed block of 180,000 shares against an indicated baseline of 204,296,493 shares (listed in the excerpt). Prior 10b5-1 sales in late 2025 and early 2026 are documented with specific share counts and dollar amounts.
Any market impact depends on execution method and timing, which the excerpt does not specify; trading under a 10b5-1 plan typically follows pre-set instructions rather than discretionary timing.
FAQ
What does the ALHC Form 144 filed by JEK TRUST report?
Who appears as the seller and broker in the filing for ALHC?
Does the filing show prior sales by the same trust?
Do the documents state how the shares will be sold or who receives proceeds?
Is this Form 144 an indication of discretionary insider selling for ALHC?